(Q44775602)

English

Efficacy of 2-week, second-line Helicobacter pylori eradication therapy using rabeprazole, amoxicillin, and metronidazole for the Japanese population

scientific article published in June 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 December 2017

Efficacy of 2-week, second-line Helicobacter pylori eradication therapy using rabeprazole, amoxicillin, and metronidazole for the Japanese population (English)

1 reference

Europe PubMed Central

6 December 2017

Helicobacter pylori

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Takayuki Matsumoto

3

object named as

Takayuki Matsumoto

1 reference

Europe PubMed Central

6 December 2017

author name string

Kazutoshi Hori

1

1 reference

Europe PubMed Central

6 December 2017

Hiroto Miwa

2

1 reference

Europe PubMed Central

6 December 2017

publication date

1 June 2011

1 reference

Europe PubMed Central

6 December 2017

1 reference

Europe PubMed Central

6 December 2017

16

1 reference

Europe PubMed Central

6 December 2017

3

1 reference

Europe PubMed Central

6 December 2017

234-240

1 reference

Europe PubMed Central

6 December 2017

Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00842.X

21 January 2018

Changes in 12-Year First-Line Eradication Rate of Helicobacter pylori Based on Triple Therapy with Proton Pump Inhibitor, Amoxicillin and Clarithromycin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00842.X

21 January 2018

Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00842.X

21 January 2018

Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00842.X

21 January 2018

Helicobacter pylori eradication: role of individual therapy constituents and therapy duration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00842.X

21 January 2018

Helicobacter pylori eradication therapy success regarding different treatment period based on clarithromycin or metronidazole triple-therapy regimens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00842.X

21 January 2018

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00842.X

21 January 2018

Bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate in Korea

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00842.X

21 January 2018

Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00842.X

21 January 2018

A new eradication resistance index as a predictor of metronidazole-containing second-line treatment of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00842.X

21 January 2018

Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00842.X

21 January 2018

Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00842.X

21 January 2018

High-dose rabeprazole-amoxicillin versus rabeprazole-amoxicillin-metronidazole as second-line treatment after failure of the Japanese standard regimen for Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00842.X

21 January 2018

Tetracycline, metronidazole and amoxicillin-metronidazole combinations in proton pump inhibitor-based triple therapies are equally effective as alternative therapies against Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00842.X

21 January 2018

Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00842.X

21 January 2018

Long-term follow-up of 13C-urea breath test results after Helicobacter pylori eradication: frequency and significance of borderline delta13CO2 values

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00842.X

21 January 2018

Urease-positive bacteria in the stomach induce a false-positive reaction in a urea breath test for diagnosis of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00842.X

21 January 2018

Quadruple therapy with ecabet sodium, omeprazole, amoxicillin and metronidazole is effective for eradication of Helicobacter pylori after failure of first-line therapy (KDOG0201 Study).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00842.X

21 January 2018

A prospective study of acute drug-induced liver injury in patients suffering from non-alcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00842.X

21 January 2018

Steatosis as a cofactor in other liver diseases: hepatitis C virus, alcohol, hemochromatosis, and others.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00842.X

21 January 2018

Identifiers

10.1111/J.1523-5378.2011.00842.X

1 reference

Europe PubMed Central

6 December 2017

1 reference

Europe PubMed Central

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44775602&oldid=2040310935"